NEW YORK, United States, and LONDON, United Kingdom, March 30, 2026

Physitrack today announced a new commercial agreement with a New York state-based academic medical center to deliver the Physitrack platform.

The agreement is valued at $100,556 in total contract value and $31,897 in annual recurring subscription revenue, with revenue recognition expected to commence in Q2 2026.

Subsequent phases of the agreement may include expanded scope and additional user licenses, with the potential to generate additional recurring revenue.

Under the agreement, Physitrack will provide its digital rehabilitation and clinical exercise prescription platform to 190 clinician users, enabling the customer to:

• Improve access to rehabilitation care and remote patient monitoring across clinical teams
• Scale digital home exercise programme delivery and patient education through a single integrated platform
• Enhance clinical outcomes tracking and patient engagement through integrated telehealth capabilities

The solution supports patients and clinical staff by delivering streamlined, evidence-based rehabilitation workflows that improve both clinician efficiency and patient outcomes.

This agreement reflects continued strong demand for Physitrack's platform within the US academic medical centre market and aligns with the company's strategy to expand its enterprise footprint across North America and grow predictable recurring revenue. This new customer relationship highlights Physitrack's ability to win enterprise clients within the US healthcare system.

Henrik Molin, Physitrack CEO and Founder, comments:
"We are pleased to announce this agreement, which further demonstrates the strength and versatility of the Physitrack platform. This kickstarts our expansion in the Americas, led by Physitrack's New York office, and we look forward to building on this momentum with more growth to come. We continue to support our partners in delivering better outcomes while building predictable, recurring revenue for the company."